CompletedPhase 4

Intrapleural Bupivacaine for Ipsilateral Shoulder Pain After Thoracotomy

Canada42 participantsStarted 2017-07-01

Plain-language summary

While thoracic epidural could control incisional pain after thoracotomy, an excruciating ipsilateral shoulder pain happens post thoracotomy and could affect up to 85% of thoracotomy patients. It is often difficult to manage and relatively resistant to opioids. The investigators postulate that in the presence of a functioning thoracic epidural, intrapleural bupivacaine administered through the chest tube could be effective in reducing post thoracotomy ipsilateral shoulder pain.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and Female, between 18 and 80 years, ASA 1-3, Scheduled for open thoracotomy Exclusion Criteria: * ASA \>3, morbid obesity BMI\>40, Previous cardiac or ipsilateral thoracic surgery, Renal or hepatic failure, anemia, allergy to local anesthetics, contraindications to receive regional anesthesia, patient refusal, reiteration due to complication

What they're measuring

Change in VAS scores

Timeframe: from 0 hour to 24 hour

Trial details

NCT IDNCT03862404

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-02-15

View on ClinicalTrials.gov More Post Thoracic Surgery trials